Crystal deal toy marking the sale of a royalty interest in OXLUMO. OXLUMO has been approved by both the Food and Drug Administration (FDA), and the European Medicine’s Agency (EMA).
(21ALJ215)
Crystal deal toy marking the sale of a royalty interest in OXLUMO. OXLUMO has been approved by both the Food and Drug Administration (FDA), and the European Medicine’s Agency (EMA).
(21ALJ215)Crystal deal toy marking a capital raise by eye care firm Visioneering Technologies.
(21ALJ208)Crystal deal toy commemorating Series A financing for Interius BioTherapeutics, a preclinical stage gene therapy firm.
(21AKL266)Lucite deal toy celebrating the acquisition of DivvyDose, The Illinois-based online pharmacy delivers pills in pre-sorted packs.
(21AKL199)Custom crystal, incorporating a map of the U.S., celebrating the 10th anniversary of LifePoint Health. The Tennessee-based healthcare company operates a national network of hospitals.
(21AKL090)Crystal deal toy celebrating the partnering of EMS firms LifeCare Medical Transports and Priority Ambulance.
(9ACJ293)Custom deal toy celebrating a follow-on public offering by Applied UV, a technology company employing narrow-range ultra violet light (UVC) to combat pathogens.
(20AJH232)Lucite deal toy celebrating an investment in GC Rieber VivoMega, a Norwegian supplier of Omega-3 concentrates.
(21LJW034)Crystal deal toy marking the acquisition of healthcare services company CareAccess MSO.
(21AKL091)
